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Abstract
Background: Inflammation-mediated hyperalgesia involves tissue acidosis and sensitization of
nociceptors. Many studies have reported increased expression of acid-sensing ion channel 3
(ASIC3) in inflammation and enhanced ASIC3 channel activity with pro-inflammatory mediators.
However, the role of ASIC3 in inflammation remains inconclusive because of conflicting results
generated from studies of ASIC3 knockout (ASIC3-/-) or dominant-negative mutant mice, which have
shown normal, decreased or increased hyperalgesia during inflammation.
Results: Here, we tested whether ASIC3 plays an important role in inflammation of subcutaneous
tissue of paw and muscle in ASIC3-/- mice induced by complete Freund's adjuvant (CFA) or
carrageenan by investigating behavioral and pathological responses, as well as the expression profile
of ion channels. Compared with the ASIC3+/+ controls, ASIC3-/- mice showed normal thermal and
mechanical hyperalgesia with acute (4-h) intraplantar CFA- or carrageenan-induced inflammation,
but the hyperalgesic effects in the sub-acute phase (1–2 days) were milder in all paradigms except
for thermal hyperalgesia with CFA-induced inflammation. Interestingly, carrageenan-induced
primary hyperalgesia was accompanied by an ASIC3-dependent Nav1.9 up-regulation and increase
of tetrodotoxin (TTX)-resistant sodium currents. CFA-inflamed muscle did not evoke hyperalgesia
in  ASIC3-/-  or  ASIC3+/+ mice, whereas carrageenan-induced inflammation in muscle abolished
mechanical hyperalgesia in ASIC3-/- mice, as previously described. However, ASIC3-/- mice showed
attenuated pathological features such as less CFA-induced granulomas and milder carrageenan-
evoked vasculitis as compared with ASIC3+/+ mice.
Conclusion: We provide a novel finding that ASIC3 participates in the maintenance of sub-acute-
phase primary hyperalgesia in subcutaneous inflammation and mediates the process of granuloma
formation and vasculitis in intramuscular inflammation.
Background
Inflammation, the complex reaction of the body to harm-
ful stimuli, is often accompanied by redness, swelling,
pain and heat. During inflammation, damaged tissues
release pro-inflammatory mediators such as bradykinin,
serotonin, histamine, nerve growth factor, prostaglandin,
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neuropeptides and cytokines to activate immune cells and
neurons [1]. These factors serve a protective purpose by
stimulating the immune system, which causes vasodilata-
tion to allow the exudation of plasma and leukocytes into
the surrounding tissues, whereby the harmful stimuli are
removed and the injured tissue undergoes repairing. The
extravasation of leukocytes and plasma fluid into the tis-
sue accounts for the swelling of the tissue, whereas the
increased blood flow is responsible for the heat and red-
ness.
Inflammation also causes tissue acidosis, whereby high
concentrations of protons are the direct cause of pain
[2,3]. Acid-sensing ion channel 3 (ASIC3) is the most sen-
sitive nociceptive ion channel responding to tissue acido-
sis [3,4]. During inflammation, lactic acid, arachidonic
acid and nitric oxide sensitize ASIC3 [5-7]. Up-regulation
of ASIC3 is seen in inflamed human intestine [8] and dor-
sal root ganglia (DRG) of rodents with inflamed hind
paws [9,10].
Two experimental models of inflammation have been
widely used in research of pain. Complete Freund's adju-
vant (CFA) is composed of an antigen solution of heat-
inactivated bacterium, Mycobacterium tuberculosis, emulsi-
fied in mineral oil, which can potentiate the cell-mediated
immune response and the production of immunoglobu-
lins [11]. A single injection of CFA into the plantar surface
of the paw induces intense and persistent inflammation at
local injection sites and occasionally at distant locations
because of its systemic spread [12]. In contrast, carra-
geenan is thought to produce non-immune-mediated
inflammation [13]. A subcutaneous injection of carra-
geenan induces inflammatory responses initially medi-
ated by mast cells and neutrophils, and then followed by
a phagocytic response, which depends on the mobiliza-
tion of macrophages. The behavior of ASIC3-/- mice has
been studied largely with the carrageenan inflammation
model but with discrepant results [14-17]. Interestingly,
these previous studies imply that ASIC3 might be
involved in the development of secondary but not pri-
mary hyperalgesia produced by inflammation [16,17].
Sensory neurons innervating muscle and those innervat-
ing skin are considered to have different properties, and
ASIC3 is more likely expressed in the former than in the
latter [18]. To reveal the functional role of ASIC3 in
inflammation, we systematically studied thermal and
mechanical hyperalgesia induced by CFA and carrageenan
in the paw and muscle of ASIC3+/+ and ASIC3-/- mice. Tis-
sue underwent pathological examination and real-time
PCR to reveal the gene regulation of ion channels depend-
ent on ASIC3 following inflammation.
Results
Behavior tests
ASIC3+/+  and  ASIC3-/-  mice did not differ in baseline
responses to thermal and mechanical stimuli or responses
in left and right paws. No hyperalgesic effect was observed
on the contralateral sides of the injections at most times
during this study (Additional file 1).
Thermal hyperalgesia developed in both ASIC3+/+ and
ASIC3-/- mice as soon as 4 h after injection of CFA or car-
rageenan into paws of both genotypes (Fig. 1A), which
persisted for 7 days for both inflammatory models.
Although both ASIC3+/+  and  ASIC3-/-  mice showed
increased sensitivity to heat, the latter showed longer
withdrawal latency from 4 h to 2 days than the former in
the carrageenan inflammatory model. The difference was
small but significant after 4 h, with a mean latency of 3.20
sec and 2.09 sec for ASIC3-/- and ASIC3+/+ mice, respec-
tively (P < 0.05). On days 1 and 2, paw withdrawal latency
for ASIC3+/+ mice remained short (mean latency 2.49 sec
for day 1 and 2.66 sec for day 2), but the magnitude of
hyperalgesia was significantly lower for ASIC3-/-  mice
(mean latency 4.44 sec for day 1 and 5.96 sec for day 2
than that of ASIC3+/+ mice (P < 0.05).
Neither ASIC3+/+ nor ASIC3-/- mice showed a response to
von Frey filaments following saline injection, but both
developed mechanical hyperalgesia in CFA and carra-
geenan inflammatory models; however, the mechanical
hyperalgesia was much milder and more transient in
ASIC3-/- mice than in ASIC3+/+ mice (Fig 1B). Of 5 applica-
tions of the filaments, ASIC3+/+ mice with CFA-inflamed
paws responded 3–4 times on days 1 and 2, whereas
ASIC3-/- mice responded only 1–2 times and only on day
1. Both ASIC3+/+  and  ASIC3-/-  mice with carrageenan-
induced inflammation showed hyperalgesia at a compara-
ble level at 4 hr after injection. Hyperalgesia in ASIC3+/+
mice continued to increase on days 1 and 2 but decreased
in ASIC3-/- mice. On day 7, ASIC3+/+ mice still showed
mechanical hyperalgesia as compared with at baseline but
not ASIC3-/- mice.
To test whether the ASIC3 gene plays a role in intramus-
cular inflammation, CFA or carrageenan was injected into
gastrocnemius muscle. Then thermal and mechanical tests
were applied to the ipsilateral paw, not the inflammatory
muscular site, to measure the effect of secondary hyperal-
gesia. Muscular inflammation had no effect on paw sensi-
tivity to heat stimuli in both genotypes of mice, regardless
of the inflammatory agents (Fig. 2A). In ASIC3+/+ mice, no
significant increase in mechanical sensitivity was observed
with CFA-induced inflammation throughout the test
period or carrageenan-induced inflammation on day 1.
However, mechanical hyperalgesia developed on day 2 inMolecular Pain 2009, 5:1 http://www.molecularpain.com/content/5/1/1
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carrageenan-injected ASIC3+/+ mice (Fig. 2B) but did not
develop in ASIC3-/- mice.
Examination of pathological specimensTo associate the
previously mentioned behavioral changes induced by
pain as a result of inflammatory states in these mice, we
performed histopathological examination of tissue
changes in these samples. For intraplantar injections,
remarkable paw edema and redness occurred as soon as 4
h after injection and persisted for 7 days, with variations
in the appearance of these inflammatory sites. In 2 of 6
ASIC3+/+ mice injected with carrageenan, the inflamma-
tion was so severe that black bruises, indicative of subcu-
taneous hemorrhage in the paw, became evident.
Measurement of paw thickness 4 h and 2 and 7 days after
the injections of CFA or carrageenan showed significant
swelling, with carrageenan causing swelling at all time
points (Fig. 3); however ASIC3+/+ and ASIC3-/- mice did
not differ in paw thickness. Histological examination
revealed edema and mixed inflammatory infiltration
composed of neutrophils and mononuclear inflamma-
tory cells in paw sections of both mice (Fig. 4 &5). The
inflammatory infiltration was evident at all time points
but was milder at 4 h than at days 2 and 7 (Fig. 4C–F &
Fig. 5C–F).
Gross examination of the injection sites of normal saline
and CFA was unremarkable, but large areas of hemor-
rhage could be seen in carrageenan-induced inflamed
muscles after skin was removed on day 2. Histologically,
the muscle sections of saline groups revealed intact and
well-organized muscular fibers, connective tissue and vas-
cular channels with mild infiltration of leukocytes found
along the needle tracks in some cases (Fig. 6A). However,
marked infiltration of mononuclear inflammatory cells
(most likely macrophages) and edema evidenced by the
spaces between muscular fibers was observed with CFA
injection (Fig. 6B &6C). The inflammatory cells infiltrated
endomysial and perimysial connective tissue and caused
focal destruction of the myocytes (Fig. 6D). Large round
Intraplantar inflammation-mediated hyperalgesia Figure 1
Intraplantar inflammation-mediated hyperalgesia. Results of ipsilateral side only. A, Thermal hyperalgesia test. B, von 
Frey filament test. WT: ASIC3+/+ mice, n = 6 in each group. KO: ASIC3-/- mice, n = 6 or 7 in each group. *p < 0.05, **p < 0.01, 
***p < 0.001 compared to baseline. #p < 0.05, ##P < 0.01 comparison between ASIC3+/+ and ASIC3-/- groups. CFA = complete 
Freund's adjuvant
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to oval empty spaces representing the deposition of the
lipid content from CFA were frequently surrounded by
inflammatory infiltrates and the formation of granulomas
with epithelioid macrophages was evident (Fig. 6E &6F).
CFA contained M. tuberculosis and mineral oil, which
might well account for the formation of granulomas from
day 2. Well-formed granulomas defined by compact, well-
circumscribed structures composed of epitheloid macro-
phages were characteristic of ASIC3+/+ mice (Fig 6E), but
most of the granulomas found in ASIC3-/- mice were small
and ill-defined (Fig. 6F). The mean density of granulomas
was 0.80 ± 0.23/mm2 for ASIC3+/+ mice and 0.24 ± 0.08/
mm2 for ASIC3-/- mice (p < 0.05) (Fig. 7A). In parallel of
this, the myocytes in ASIC3+/+ mice showed more severe
damage than those in ASIC3-/- mice, with more myocytes
exhibiting variation in fiber size, centrally located nuclei
and invasion by inflammatory cells (Fig. 6B–D). These
data indicate that the inflammatory response and subse-
quent muscular damage induced by CFA injection were
milder in the absence of the ASIC3 gene.
Injection of carrageenan produced a different type of his-
topathology. Carrageenan appeared as an amorphous
pink substance permeating the intercellular space, which
induced inflammatory infiltration and extravasation of
red blood cells or hemorrhage in severe cases. Inflamma-
tory infiltration into the muscle and subcutaneous fat lob-
ules caused rhabdomyolysis and panniculitis in both
ASIC3+/+ and ASIC3-/- mice (Fig. 8A &8D). Interestingly,
inflammatory infiltration was also seen in some of the
vascular walls and caused vascular wall destruction or vas-
culitis (Fig. 8B &8E). The lining of endothelial cells
appeared prominent in the damaged areas. Small black
granules or nuclear dusts within the disrupted vascular
walls were also noted (Fig. 8B &8C). Carrageenan-
induced vasculitis might be responsible for the hemor-
rhage described earlier and contributed to rhabdomyoly-
sis. Interestingly, vasculitis was observed only within veins
in this model. Also, the proportion of vessels affected by
vasculitis seemed to be higher in ASIC3+/+ mice than in
ASIC3-/- mice (69.02% vs. 31.13% P < 0.05) (Fig. 7B).
Intramuscular inflammation-mediated hyperalgesia Figure 2
Intramuscular inflammation-mediated hyperalgesia. Results of ipsilateral side only. A, Thermal hyperalgesia test. B, 
von Frey filament test. WT: ASIC3+/+ mice, n = 6 in each group. KO: ASIC3-/- mice, n = 6 in each group. **p < 0.01 compared to 
baseline. #p < 0.05 comparison between ASIC3+/+ and ASIC3-/- groups. CFA = complete Freund's adjuvant
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To further identify the precise location of ASIC3-contain-
ing afferents in inflamed sites, we stained frozen muscle
sections with antibodies against ASIC3 and PGP9.5,
which is an ubiqutin C-terminal hydrolase specifically
expressed in most neurons [19]. We first confirmed that
the ASIC3 immunoreactivity was found in vessels and
nerve bundles in non-inflamed areas as previously
described (Fig. 9A–G) [18]. In CFA-inflamed muscle, no
obvious ASIC3 or PGP9.5 immunoreactivities were found
in areas surrounding granuloma (Fig. 9H–K). In contrast,
in carrageenan-inflamed muscle, the location of ASIC3
immunoreactivity was often found on vessels with vasu-
clitis (Fig. 9L–O).
Gene expression in DRG
To investigate which genes might be involved in the devel-
opment of hyperalgesia, we examined the transcript levels
of ASIC3, Nav1.6, Nav1.7, Nav1.8, Nav1.9 and TRPV1 nor-
malized to GAPDH in DRGs of mice 2 days after inflam-
mation induction.
In ASIC3+/+ mice, only Nav1.9 was up-regulated 2 days
after intraplantar carrageenan-induced inflammation
(Fig. 10 & Additional file 2). Nav1.9 expression with car-
rageenan injection was significantly increased by twofold
as compared with saline injection (mean ΔCT to GAPDH
3.36 cycles vs. 1.98 cycles, P < 0.05). No up-regulation of
Nav1.9  could be found in DRGs of mice with CFA-
induced inflamed paws and the muscle inflammation
models (Additional file 2). This carrageenan-induced up-
regulation of Nav1.9 was also ASIC3 dependent. In con-
trast, Nav1.9 expression in ASIC3-/- mice treated with car-
rageenan did not differ from that in ASIC3-/- mice treated
with saline (Fig. 10). The expression of Nav1.9 in the car-
rageenan-treated  ASIC3-/- group was significantly lower
than in the ASIC3+/+ group (p < 0.05).
TTX-resistant sodium currents in DRG neurons
To investigate whether null mutation of ASIC3 affects the
neuronal excitability in DRG neurons during carrageenan-
induced inflammation, we conducted whole-cell patch
recording to measure the tetrodotoxin (TTX)-resistant
(TTX-R) sodium currents (Fig. 11). In small DRG neurons,
TTX-R sodium currents are composed of two distinct com-
ponents: the INav1.8 activated at about -40 mV and the
INav1.9 activated about -60 mV [20]. In the ASIC3+/+ group,
INav1.8 but not INav1.9 was significantly increased in small-
to-medium DRG neurons 2 days after intraplantar carra-
geenan-induced inflammation (Fig. 11A &11C). How-
ever, intraplantar inflammation did not alter the
amplitudes of both TTX-R currents in neurons of the
ASIC3-/- group (Fig. 11B &11D).
Discussion
Intraplantar inflammation
Previous studies found that on intraplantar inflamma-
tion,  ASIC3-/-  mice exhibited either no or slightly
enhanced hyperalgesia [14,15]. Although mouse strains
and sexes of these two studies may cause the discrepant
results from our current work, the studies used 2% carra-
geenan, and the tests were carried out only 3–4 h after
injection. In another study involving dominant-negative
Paw edema following the induction of inflammation Figure 3
Paw edema following the induction of inflammation. Measurement of thickness of ipsilateral paws swelled with inflam-
mation by both complete Freund's adjuvant (CFA) and carrageenan. A, Thickness 4 h after intraplantar injection. B, Thickness 
2 days after injection. C, Thickness 7 days after injection. WT: ASIC3+/+ mice, n = 6 in each group. KO: ASIC3-/- mice, n = 6 in 
each group. *p < 0.05, **p < 0.01, ***p < 0.001 compared with the saline control group. #p < 0.05, ##p < 0.01, ###p < 0.001 
comparison between CFA and carrageenan in the same genotype group.
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ASIC3  transgenic mice [21], behavior tests were per-
formed 1–6 h after zymosan injections to induce paw
inflammation. These mice exhibited increased mechani-
cal hypersensitivity. Although the role of ASIC3 in the
acute phase of inflammation is inconclusive, our results
indicate the involvement of ASIC3 in the sub-acute phase
of inflammation. Our study showed no difference in noci-
ceptive behaviors in the acute phase of inflammation (4
h) between two genotypes, except for a small but signifi-
cant difference in thermal hyperalgesia in the carrageenan
inflammatory model. On follow-up in ASIC3-/- mice, in
both models for mechanical hyperalgesia and in the carra-
geenan model for thermal hyperalgesia, hyperalgesia was
attenuated after intraplantar injection. The inflammation
state might have changed from an acute to a sub-acute
phase in 24 h, and ASIC3-/- mice could have recovered
faster from hyperalgesia. Although ASIC3 is believed to
play a more important role in secondary hyperalgesia
(hypersensitivity occurred in non-injured sites) induced
by inflamed muscle or joints than primary hyperalgesia in
inflamed tissues [16,17], in this study we provide evi-
dence that ASIC3 does play a role in subcutaneous pri-
mary hyperalgesia in later stages. This conclusion is also
supported by a recent report showing that subcutaneous
injection of the ASIC3-selective blocker APETx2 can alle-
viate the inflammation-induced hyperalgesia [22]. How-
ever, the role of ASIC3 for sub-acute-phase primary
hyperalgesia is not applied to the deep tissues, because a
recent study reported that ASIC3-/- mice did not show dif-
ferent levels of primary hyperalgesia in inflamed joint
induced by 3% of carrageenan than ASIC3+/+ mice [17].
We did not observe a significant difference in effects of
inflammation between ASIC3+/+  and  ASIC3-/-  mice on
pathological examination, which indicates that ASIC3
does not play a role in the development of inflammation,
and the difference in hyperalgesia may not be related to
the degree of inflammation.
During inflammation, the enhanced expression of ion
channels sensitizes primary afferent neurons and pro-
duces hyperexcitability, thereby producing hyperalgesia.
Up-regulation of ASIC3 and sodium channels during
inflammation have been documented [8-10,23-25]. How-
ever, real-time PCR results in our study showed no tran-
scriptional change in ASIC3, Nav1.6, Nav1.7, and Nav1.8
H&E sections of CFA-inflamed hind paws Figure 4
H&E sections of CFA-inflamed hind paws. Representative H&E sections obtained 4 hr, 2 and 7 days after intraplantar 
injection of CFA. A, CFA-inflamed ASIC3+/+ hind paw on day 2. B, CFA-inflamed ASIC3-/- hind paw on day 2.C, CFA-inflamed 
ASIC3+/+ hind paw at 4 hr. D, CFA-inflamed ASIC3+/+ hind paw on day 7. E, CFA-inflamed ASIC3-/- hind paw at 4 hr. F, CFA-
inflamed ASIC3-/- hind paw on day 7. Neutrophils are indicated by black arrows.
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mRNA level following inflammation. These results are
contradictory to those in previous studies. The only up-
regulated gene we found was Nav1.9, an ion channel
reported to be unchanged under intraplantar carrageenan-
induced inflammation [25]. Nav1.9 mRNA level has been
shown to increase by day 7 with CFA-induced inflamma-
tion [26]; however, its expression was not changed in our
CFA model. A possible explanation for the discrepancy
between our study and previous studies is the difference in
sampling and signal quantification. Previous studies used
methods such as RT-PCR, in situ hybridization or immu-
nostaining, which were semi-quantitative. Furthermore,
both in situ hybridization and immunostaining examine
one plane of cells, whereas with real-time PCR, the total
mRNAs from all cellular populations in a single DRG were
quantified. Lack of transcriptional change in a single DRG
by real-time PCR cannot rule out the possibility of up- or
down-regulated genes in subgroups of cells or involve-
ment of the gene in posttranscriptional regulation for the
process of sensitization. Another issue to consider is the
timing of sampling, since regulation of these genes might
be transient and time dependent. Animal species and
genetic background may also account for the discrepan-
cies to a certain extent, because mice express relatively less
ASIC channels in DRGs than do rats [27,28].
The up-regulation of Nav1.9 on day 2 with intraplantar
carrageenan-induced inflammation was significant and
ASIC3 dependent. The functional importance of Nav1.9
in modulation of pain behavior in inflammation has been
previously investigated by disrupting the ion channel in
mice [29]. Mechanical and thermal thresholds are compa-
rable between Nav1.9-/- and wild-type mice in the absence
of injury. In contrast, inflammation-mediated pain
behavior differs prominently in Nav1.9-/- mice as com-
pared with wild-type mice. Intraplantar injection of carra-
geenan induced thermal hyperalgesia in both wild-type
and Nav1.9-/- mice in the first 3 h post-injection; however,
the hyperalgesia was diminished 24 h later in Nav1.9-/-
mice. This finding matches our observation of ASIC3-/-
mice with longer paw withdrawal latency starting at 4 h
and continuing through day 2, which is indicative of
attenuated thermal hyperalgesia.
H&E sections of carrageenan-inflamed hind paws Figure 5
H&E sections of carrageenan-inflamed hind paws. Representative H&E sections obtained 4 hr, 2 and 7 days after intra-
plantar injection of carrageenan. A, Carrageenan-inflamed ASIC3+/+ hind paw on day 2. B, Carrageenan-inflamed ASIC3-/- hind 
paw on day 2. C, Carrageenan-inflamed ASIC3+/+ hind paw at 4 hr. D, Carrageenan -inflamed ASIC3+/+ hind paw on day 7. E, 
Carrageenan-inflamed ASIC3-/- hind paw at 4 hr. F, Carrageenan-inflamed ASIC3-/- hind paw on day 7. Neutrophils are indicated 
by black arrows and mononuclear cells are indicated by yellow arrows.
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The similar phenotypes in the pain behavior for Nav1.9-/-
and ASIC3-/- mice under inflammation and the ASIC3-
dependent up-regulation of Nav1.9 suggest that inflam-
mation induces tissue acidosis, which leads to activation
of ASIC3 and subsequent ASIC3-dependent up-regulation
of Nav1.9; the increased Nav1.9 level in turn contributes
to thermal hyperalgesia. In the absence of ASIC3, Nav1.9
cannot be up-regulated, and thermal hyperalgesia
becomes attenuated.
In contrast to up-regulation of Nav1.9 transcripts, increase
of INav1.8 on day 2 with intraplantar carrageenan-induced
inflammation was significant and ASIC3 dependent on
electrophysiology (Fig. 11). Although our electrophysi-
olgical data did not show increased INav1.9 in overall small
to medium neurons to support the up-regulation of
Nav1.9 transcripts during inflammation, we did find a sig-
nificant increase of INav1.9 in neurons that did not express
Nav1.8 activity in ASIC3+/+ mice (65.4 ± 16.0 vs. 506.5 ±
147.7 pA for the control vs. carrageenan group, respec-
tively, P < 0.05). Further study would aim to determine
whether a specific subset of DRG neurons plays an impor-
tant role in regulating the ASIC3-dependent effect during
inflammation. However, the increase in INav1.8 was robust,
with an increase of up to threefold in peak amplitudes,
which was associated with maximal mechanical and ther-
mal hyperalgesia on day 2 of carrageenan inflammation.
However, a previous study reported slight change of INav1.8
peak amplitude on day 4 of carrageenan inflammation,
when the Nav1.8  mRNA was significantly up-regulated
and the current density of INav1.8 was slightly increased
[24]. Thus, the alteration of Nav1.8 activity during inflam-
mation may be time-dependent, as was seen in many
studies [25,30]. Nevertheless, the increase of INav1.8 is
intriguing because Nav1.8 is known to play a role in
mechanical nociception, and inhibition of Nav1.8 would
abolish inflammation-induced mechanical and thermal
hyperalgesia [31,32]. Therefore, the increase in Nav1.8
activity may account in part for the carrageenan-induced
mechanical hyperalgesia found in ASIC3+/+ mice but not
in ASIC3-/- mice.
Intramuscular inflammation
ASIC3  is critical for the development of secondary
mechanical hyperalgesia with muscle inflammation [16].
Our findings agree with this result and show ASIC3+/+
mice with significant mechanical hyperalgesia 2 days after
intramuscular carrageenan injection. However, we did not
CFA-inflamed muscle Figure 6
CFA-inflamed muscle. Representative H&E sections obtained 2 days after induced inflammation. A, Normal control muscle 
section. B, CFA-inflamed ASIC3+/+ muscle. Myocytes were separated and rounded up with leukocytes migrated into the inter-
cellular space. Lipid drops surrounded by mononuclear cells were seen. C, CFA-inflamed ASIC3-/- muscle. D, A higher magni-
tude picture taken from CFA-inflamed ASIC3+/+ muscle. Black arrow shows a myocyte being invaded by mononuclear cells. 
White arrow indicates the centralized nucleus in a myocyte. E, Well-formed granulomas (black arrow) in CFA-inflamed ASIC3+/
+ muscle. F, An ill-defined granuloma (black arrow) in CFA-inflamed ASIC3-/- muscle.
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observe thermal hyperalgesia in either genotype with car-
rageenan-induced inflammation as was reported for
C57BL6 mice [16]. Perhaps the time to establish second-
ary thermal hyperalgesia in CD1 mice is longer than is
needed in C57BL6 mice.
In inflamed muscle, ASIC3-/-  mice seemed to display
milder pathological features, including infiltration of leu-
kocytes, formation of granulomas and vasculitis, than
ASIC3+/+ mice. Previous reports described the same path-
ological responses in both genotypes, and an assessment
of neutrophilic activity by myeloperoxidase in carra-
geenan-inflamed muscle also suggested that ASIC3 played
no role in the development of inflammation [16].
Although neutrophilic activity represents only one aspect
of inflammation, the type of immune cells recruited and
their organization and behavior vary by inflammatory
conditions. As we examined closely, the inflammation
processes involved in CFA- or carrageenan-induced
inflammation are not simple. Carrageenan-induced vas-
culitis was not documented, although in one study histo-
logical examination was carried out to characterize the
transition of immune cell-type from acute to chronic
inflammation of the rat leg muscle [33]. Also, CFA has not
been used as a muscle inflammation model; thus, no
report of its effect on granuloma formation in muscle
exists.
The development of granulomas and vasculitis involves
complicated interaction among immune cells, cytokines
and chemokines. Granulomas are the aggregation of
mononuclear inflammatory cells and modified macro-
phages organized in a compact nodule, with involvement
by a complicated interaction between antigen-presenting
macrophages and T lymphocytes mediated by various
cytokines [34]. However, the pathogenesis of vasculitis is
still not well understood, but endothelium injury is gen-
erally believed to be the fundamental event in its develop-
ment. Responding to neuropeptides (substance P or
calcitonin gene-related peptide), endothelial cells mediate
several features of chronic inflammation such as vasodil-
atation, leukocyte migration, cytokine production and
cellular adhesion molecule expression [35]. During vascu-
lar tone regulation and interaction with immune cells,
damage to endothelial cells could occur [36].
The involvement of ASIC3, an ion channel present on
neurons, in the pathogenesis of these features is thus
intriguing. The interplay between the neuronal and
immune system has become an interesting topic recently;
body systems do not work alone. Neurons could initiate a
cascade of cytokine synthesis and release and recruitment
of inflammatory machinery. The process is neurogenic
inflammation, whereby small-diameter sensory neurons
release neuropeptides such as substance P and calcitonin-
gene related peptide upon activation. Blocking nerves
results in decreasing the inflammation consequences of
carrageenan-induced inflammation [37]. ASIC3 could
thus participate in the pathogenesis of granuloma forma-
tion and vasculitis through activating neurogenic inflam-
Comparison of inflammatory features of muscle of ASIC3+/+ and ASIC3-/- mice at day 2 Figure 7
Comparison of inflammatory features of muscle of ASIC3+/+ and ASIC3-/- mice at day 2. A, Density of well-formed 
granuloma was significantly higher in ASIC3+/+ (WT) mice than in ASIC3-/- (KO) mice (n = 4). B, The proportion of vasculitic ves-
sels to total vessels was significantly greater in ASIC3+/+ mice (n = 4) than in ASIC3-/- mice (n = 5). *p < 0.05
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mation. Lacking ASIC3 may alter the properties of sensory
neurons [38], thus influencing its neurogenic release and
the inflammatory consequences. This point should be fur-
ther investigated. However, the immune system could
also affect how the neural system perceives pain through
activated mast cells, macrophages, neutrophils, and the
cytokines they release [1]. ASIC3-mediated inflammation
could be essential for the hyperalgesia we observed in
wild-type mice.
Conclusion
Here we systematically characterized changes in behavior,
pathology, gene expression, and TTX-resistant sodium
currents following inflammation induced by CFA and car-
rageenan in ASIC3-/- and ASIC3+/+ mice and showed that
the deletion of the ASIC3 gene affected features in both
inflammation models. The ASIC3-/- mice displayed milder
symptoms of inflammation than the ASIC3+/+ mice. These
findings suggest that ASIC3 mediates the sub-acute phase
of primary hyperalgesia produced by inflammation, and
the ASIC3-mediated responses to inflammation in the
paw differ from those in muscle. ASIC3 participates in the
development of sub-acute-phase hyperalgesia by up-regu-
lating Nav1.9 and TTX-R currents in subcutaneous inflam-
mation and mediates the process of granuloma formation
or vasculitis in muscular inflammation.
Methods
Animals
Adult (8- to 12-week-old) female CD1 mice were kept in
a 12 h light-dark cycle with sufficient water and food.
ASIC3-/- mice were produced as described [15] and back-
crossed with CD1 mice for more than 10 generations [28].
ASIC3+/+ and ASIC3-/- mice were offspring of heterozygous
(ASIC3+/-) intercrosses. The behavioral experiments and
examination of pathology were conducted blinded to ani-
mal genotype. All experimental protocols were approved
by the Institute of Animal Care and Use Committee of
Academia Sinica. Animals were bred and taken care of in
accordance with the current Guide for the Use of Labora-
tory Animals (National Academy Press, Washington DC).
Inflammatory models
ASIC3+/+ (n = 72) and ASIC3-/- (n = 73) mice were divided
into 6 groups. Under anesthesia with 2% halothane
(Halocarbon laboratory), 3 groups (~18 mice for each) of
Carrageenan-inflamed muscle Figure 8
Carrageenan-inflamed muscle. Representative H&E sections were obtained 2 days after carrageenan injection. A-C, H&E 
sections from ASIC3+/+ mice. A, Carrageenan-inflamed ASIC3+/+ muscle. Carrageenan filled in the intercellular matrix, causing 
inflammation. B, Vasculitis in carrageenan-inflamed ASIC3+/+ muscle. The arterial wall (right) was intact, but the vein (left) 
showed vasculitis. C, Higher magnitude of bracket area from B. Black granules were deposited on the vascular wall (arrows) 
and the lining of the lumen was incomplete. D-F, H&E sections from ASIC3-/- mice. D, Carrageenan-inflamed ASIC3-/- muscle. E, 
Vein (right) and artery (left) remained integrated in carrageenan-inflamed ASIC3-/- muscle. F, Higher magnitude of bracket area 
from E.
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each genotype were given a single injection of 20 μl saline
(pH 7.4, buffered with 20 mM HEPES to rule out the
effects of acidic saline), CFA (0.5 mg/ml heat-killed M.
tuberculosis [Sigma, St. Louis, MO] suspended in oil:saline
1:1 emulsion) or 3% carrageenan (lambda carrageenan,
type IV; Sigma) in the plantar surface of the left hind paw
(Day 0) to induce intraplantar inflammation. Behavioral
assessments were conducted at 4 h, 1 day, and 2 and 7
days after induction of inflammation, and DRG were har-
vested at 4 h and days 2 and 7. For this purpose, 6 mice
from each group were tested for mechanical responses
after 4 h, and then killed; another 6 mice, were tested for
behavioral response to pain at days 0, 1 and 2, and then
killed at day 2; another 6 mice, for thermal responses 4 h
after injection and again for both behavioral assessments
at day 7. The other 3 groups (6 mice for each group) of
each genotype received an injection of saline, CFA or car-
rageenan in the left gastrocnemius muscle belly to induce
intramuscular inflammation. Behavior was tested at days
0, 1 and 2, and mice were killed on day 2.
ASIC3-containing afferents in inflamed muscle Figure 9
ASIC3-containing afferents in inflamed muscle. Red labeling shows secondary antibodies conjugated with Alexa Fluor-
594, green with Alexa Fluor-488. A, B, C, ASIC3 immunoreactive nerves were found surrounding the vessels and co-localized 
with PGP9.5. D, E, F, G, In nerve bundles, ASIC3 immunoreactivity was co-localized with PGP9.5 (yellow spots in G). H, I, J, 
K, ASIC3 and PGP9.5 had no immunoreactivity in areas surrounding granuloma. L, M, N, O, ASIC3 and PGP9.5 immunoreac-
tive nerves were found on a vessel with vasculitis. A, D, H, L, shows the contrast pictures. Yellow or black arrows indicate 
the co-localization of ASIC3 and PGP9.5; the red arrow indicates positive staining for PGP9.5 but not ASIC3. The arrowhead 
shows a well-formed granuloma.
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Assessment of thermal and mechanical hyperalgesia
Thermal and mechanical sensitivities were tested prior to
(day 0) and at 4 h and days 1, 2, and 7 following injec-
tions. All tests were performed at constant room tempera-
ture of 24°C, and stimuli were applied only when mice
were calm but not sleeping or grooming. If both tests were
performed on the same day, mechanical responses were
first assessed, and then thermal tests were performed at
least 1 h later.
For thermal sensitivity assessment, mice were moved to a
small cubicle on a glass platform and allowed to habituate
for 1 h. The radiant heat source was directed to the plantar
surface of one hind paw through the glass until the mouse
withdrew its paw. The latency of paw withdrawal from the
onset of stimulation was measured sequentially for both
hind paws by use of an IITC analgesiometer (IITC Life Sci-
ences, Woodland Hills, CA). The light intensity was set to
obtain a baseline response time of approximately 10 sec.
The cut-off time was set to 30 sec to minimize heat dam-
age to the skin. Sensitivity of each hind paw was measured
with 3 trials, with a 10-min recovery period between each
trial. The response was determined by the paw withdrawal
latency defined by the mean from 3 trials at each time
point.
Mechanical sensitivity was measured by testing the
number of responses to stimulation with five applications
of von Frey filaments. Mice were placed on an elevated
wire mesh platform in a plexi-glass chamber and allowed
1 hr for acclimatization. A von Frey filament of 0.02 g
bending force was used as a baseline stimulation. Fila-
ments were briefly applied 5 times to each hind paw, with
a 30-sec interval between each application. A response
was considered valid with an abrupt foot lift on applica-
tion of the von Frey filament.
Examination of pathologic specimens
Mice were sacrificed by use of CO2, and paw thickness was
measured at the metatarsal level. The inflamed left hind
paw or leg muscle was dissected, fixed in 4% paraformal-
dehyde overnight and then embedded in paraffin. Paws
were decalcified before embedding. Sections were depar-
affinized and underwent H&E staining. All sections were
examined under a light microscope independently by two
pathologists. The inflamed muscle sections were further
analyzed by determining the number of granulomas or
the percentage of vessels showing vasculitis. For CFA-
inflamed muscle, the total area of the muscle cross-sec-
tions was determined by use of ImageProPlus software,
and the number of well-formed granulomas was counted.
A well-formed granuloma was defined as a compact, cir-
cumscribed structure with epithelioid macrophages. Vas-
cular changes, including integrity of endothelial lining
and vessel wall, perivascular extravasation of erythrocytes,
in carrageenan-inflamed muscle were inspected. Infiltra-
tion of inflammatory cells, swelling of endothelial cells
and apoptotic bodies were used to define vasculitis. These
studies were conducted blinded to the genotype of the
mice.
Immunocytochemistry
Mice were anesthetized with an overdose of pentobarbital
and intracardially perfused with normal saline followed
by 4% paraformaldehyde. The left gastrocnemius muscle
was immediately dissected and post-fixed with 4% para-
formaldehyde. Post-fixed tissues were placed in 30%
sucrose (in pH 7.4 PBS) overnight, then embedded in
Nav1.9 expression in L5 dorsal root ganglia (DRG) 4 hr and 2 and 7 days after intraplantar carrageenan-induced inflammation Figure 10
Nav1.9 expression in L5 dorsal root ganglia (DRG) 4 hr and 2 and 7 days after intraplantar carrageenan-
induced inflammation. Nav1.9 mRNA from the ipsilateral DRG quantified by real-time PCR and normalized to GADPH. (*p 
< 0.05, n = 3 or 4).
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OCT and rapidly frozen with use of liquid nitrogen and
stored at -80°C. Frozen sections were cut 20-μm thick on
a cryostat and mounted on glass slides. Slides were incu-
bated with blocking solution containing 3% BSA, 0.1%
Triton X-100, and 0.02% sodium azide in PBS for 90 min
at room temperature. After blocking, slides were incu-
bated with primary antibodies (rabbit anti-ASIC3, 1:500,
Alomon Lab, Jerusalem, Israel; guinea pig-anti-PGP9.5,
1:500, Chemicon, Temecula, CA) prepared in blocking
solution at 4°C overnight. Slides were visualized by use of
fluorescence-conjugated secondary antibodies (goat anti-
rabbit-Alexa Fluor-488 or goat anti-guinea pig-Alexa Fluor
594, 1:200, Invitrogen, Carlsbad, CA) and mounted on
cover slips with DAPI-containing mounting medium
(Vector, Burlingame, CA). The ASIC3 staining was elimi-
nated when the control peptides (provided by the manu-
facture) were applied (data not shown).
Gene expression in DRG
Left and right L1-L5 DRGs were harvested separately and
stored at -80°C. L1 DRGs were defined as those posterior
to the last pair of ribs. Total RNAs of DRGs were isolated
by use of the RNeasy mini kit (Qiagen, Valencia, CA)
according to the manufacturer's instructions. Each RNA
sample was eluted in 30 μl DEPC-treated water. 11 μl
from each RNA sample was mixed with 1 μl oligo(dT)18
(250 ng) and 1 μl 10 mM dNTP mix (GeneMark, Taipei,
Taiwan), heated to 65°C for 5 min and incubated on ice
Tetrodotoxin (TTX)-resistant sodium currents in lumbar DRG neurons Figure 11
Tetrodotoxin (TTX)-resistant sodium currents in lumbar DRG neurons. A, Representative TTX-R current traces in 
ASIC3+/+ mice. The TTX-R currents mediated by Nav1.8 (INav1.8) were induced by membrane depolarization from -80 to -40 
mV; TTX-R currents of INav1.9 were induced membrane depolarization from -80 to -60 mV. B, Representative TTX-R current 
traces in ASIC3-/- mice. C, Mean peak amplitudes of TTX-R currents in ASIC3+/+ mice. D, Mean peak amplitudes of TTX-R cur-
rents in ASIC3-/- mice. The number of experiments (n) is indicated above each bar. **P < 0.01.
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for at least 1 min. 4 μl 5× First-Strand Buffer, 1 μl of 0.1 M
DTT, 1 μl RNaseOUT and 1 μl SuperScript III Reverse
Transcriptase (Invitrogen, Carlsbad, CA) were then added
to the mixture and incubated at 50°C for 1 h for reverse
transcription (RT). The reaction was inactivated at 70°C
for 15 min. For real-time PCR, 12.5 μl of 2× SYBR Green
PCR Master Mix (ABI, Foster City, CA), and 0.5 μl of the
desired primer mixture were added to the RT cDNA tem-
plates to a final volume of 25 μl. PCR involved the ABI
prism 7700 sequence detector for 95°C for 10 min, fol-
lowed by 40 cycles of 95°C for 15 sec, and 60°C for 1
min. The primer sequences were as follows:
ASIC3: F 5'- CCCAGTCCGACTTTTGACAT - 3'
R 5'- CAGAGTTGAAGGTGTAGCAT - 3'
Nav1.6: F 5' - CCGATGGAAGAACGTCAAGA - 3'
R 5' - ATAATCAGGCTGCTCGTCCG - 3'
Nav1.7: F 5'- GACCTTGGCCCCATTAAATCT - 3'
R 5'- CTTGCCAGCAAACAGATTGAC - 3'
Nav1.8: F 5' - GTAGTGGTGGATGCCTTGGT - 3'
R 5'- AAGTGGCCGGTATTGTTTTG - 3'
Nav1.9: F 5'- GATGTGCCCAAGATCAAGGT - 3'
R 5'- TTCCGACGTTCAATCTTTCC - 3'
TRPV1: F 5' - TCTCCACTGGTGTTGAGACG
R 5' - GGGTCTTTGAACTCGCTGTC
GAPDH: F 5'- GGAGCCAAACGGGTCATCATCTC - 3'
R 5' - GAGGGGCCATCCACAGTCTTCT - 3'
Electrophysiology
DRG neurons of lumbar 5 segments were isolated from
mice treated with intraplantar saline or carrageenan for 2
days. DRG acute culture and settings for whole-cell patch
recording were as previously described [28]. The internal
solution contained (in mM) 10 NaCl, 110 CsCl, 20 tetra-
ethylammonium-Cl, 2.5 MgCl2, 5 EGTA, 3 Mg2+-ATP, and
5 HEPES, adjusted to pH 7.0 with CsOH. The external
solution contained (in mM) 100 NaCl, 5 CsCl, 30 tetrae-
thylammonium-Cl, 1.8 CaCl2, 1 MgCl2, 0.1 CdCl2, 25 glu-
cose, 5 4-aminopyridine, and 5 HEPES, adjusted to pH 7.4
with HCl. Osmolarity was adjusted to 290 mosmol/kg
with glucose. Before whole-cell patch recording, cells were
stained for isolectin B4(IB4)-FITC (4 μg/ml) for 2 min,
and only small- to medium-size (< 34 μm) DRG neurons
were selected for recording [28]. Recordings were per-
formed in external solution containing 200 nM TTX (Toc-
ris, Avonmouth, UK). TTX-resistant sodium currents were
evoked by a 30-ms test pulse between -70 and 0 mV in 10-
mV steps from a holding potential of -80 mV [20]. For
clarity, only the -60 and -40 mV current traces were
shown. All recording was at room temperature (21–25°C)
and completed within 24 h after plating. A total of 144
DRG neurons were patch recorded; half of them were IB4-
positive neurons.
Statistics
Data are expressed as mean ± SEM. Analysis involved use
of SAS9.1 (SAS Inst, Cary, NC). Radiant heat testing was
analyzed by two-way ANOVA followed by least squares
means post-hoc test. Mann-Whitney U-test was used to
determine differences in mechanical sensitivity between
groups and time points, differences in paw thickness,
granuloma, vasculitis, and quantitative PCR. Mean peak
amplitudes of TTX-R currents were compared between
groups via one-way ANOVA. The level of significance was
set at P < 0.05.
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